Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European CountriesFirst published 24/03/2023 Last updated 03/02/2025 EU PAS number: EUPAS103990StudyPlanned
University of Southern Denmark (SDU)Denmark First published: 01/02/2024Last updated 27/03/2024 InstitutionEducational Institution
The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)Netherlands First published: 07/01/2022Last updated 24/07/2024 InstitutionLaboratory/Research/Testing facilityENCePP partner
RTI Health Solutions (RTI-HS)FranceSpainSwedenUnited KingdomUnited Kingdom (Northern Ireland)United States First published: 21/04/2010Last updated 13/03/2025 InstitutionNot-for-profitENCePP partner
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGolSpain First published: 05/10/2012Last updated 23/02/2024 InstitutionEducational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partner